1997年中山医科大学临床医学系毕业，直接留校后在中山一院历任住院医师，主治医师，副主任医师。获肿瘤学硕士学位，长期工作在医疗、教学、科研线，积累了丰富的肿瘤诊治临床经验。擅长常见肿瘤的诊断以及化疗、靶向治疗、生物免疫治疗等肿瘤内科治疗，熟悉肺癌、乳腺癌、胃癌、结直肠癌、胆管癌、胰腺癌、前列腺癌、食管癌、肝癌、黑色素瘤、软组织肉瘤及淋巴瘤等全身各部位恶性肿瘤的全面病情评估、进展与综合治疗，对晚期恶性肿瘤病人以姑息止痛治疗、营养支持治疗为主的综合治疗有丰富的经验。尤其对各种肿瘤并发症处理，减轻化疗毒副放应等方面有独特经验。研究方向：全身各部位恶性肿瘤的治好性化疗、新辅助化疗、辅助化疗、同期化疗放疗、化疗联合靶向治疗、化疗联合生物细胞免疫治疗以及晚期肿瘤的姑息治疗、靶向治疗、免疫治疗。尤其是肺癌、乳腺癌、胃肠道恶性肿瘤的综合治疗。主要教育和工作经历：1992.9—1997.6中山医科大学临床医学系本科2009.9—2012.6中山大学肿瘤学硕士1997.7—2002.6中山大学附属医院住院医师2002.6—2015.12中山大学附属医院主治医师2016.1至今中山大学附属医院副主任医师社会兼职：◆广东省抗癌协会癌症康复与姑息治疗专业委员会青年委员◆广东省健康管理学会肿瘤防治专业委员会委员◆广州抗癌协会胃癌专业委员会委员论著：A：作者/共同/通讯作者1)Poly(AT)deletion/insertionpolymorphismoftheXPCgenecontributestourinarysystemcancersusceptibility:Ameta-ysis.Gene,2013,Oct10;528(2):335-42.(IF=2.138)作者/通讯作者2)XPCgenepolymorphismscontributetobladdercancersusceptibility:ameta-ysis.TumourBiol,2014Jan;35(1):447-53.(IF=3.611)作者/通讯作者3)XerodermapigmentosumcomplementationgroupD(XPD)genepolymorphismscontributetobladdercancerrisk:ameta-ysis.TumourBiol,2014Apr;35(4):3905-15.(IF=3.611)4)AnovelroleformicroRNA-129-5pininhibitingovariancancercellproliferationandsurvivalviadirectsuppressionoftranscriptionalco-activatorsYAPandTAZ.Oncotarget,2015Apr20;6(11):8676-86.(IF=6.359)5)Osterixtranscriptionalfactorisinvolvedinthemetastasisofhumanbreastcancers.OncolLett,2015Sep;10(3):1870-1874.(IF=1.554)6)Hypertensionasapredictivebiomarkerforefficacyofbevacizumabtreatmentinmetastaticcolorectalcancer:Ameta-ysis.JBUON,2014Dec;19(4):917-24.(IF=0.741)通讯作者7)Transarterialchemoembolizationvs.conservativetreatmentforunresectableinfiltratinghepatocellularcarcinoma:Aretrospectivecomparativestudy.MolClinOncol,2014Nov;2(6):1047-1054.8)TheGlasgowPrognosticScorepredictspoorsurvivalincisplatin-basedtreatedpatientswithmetastaticNasopharyngealCarcinoma.PLoSOne,2014Nov13;9(11):e112581.(IF=3.234)9)Predictionofoccultcervicallymphnodemetastasisinclinicallynegativesupraglotticsquamouscellcarcinoma.HeadNeckOncol,2012,Oct27;4(3):69.10)PSCAs2294008C>Tandrs2976392G>Apolymorphismscontributetocancersusceptibility:evidencefrompublishedstudies.GenesCancer,2015May;6(5-6):254-64.11)β-葡萄糖神经酰胺与HBsAg-DC瘤苗协同治疗肝癌的实验研究[J/CD].中华普通外科学文献:电子版,2013,7(4):298-302.12)奥曲肽预防伊立替康引起的迟发性腹泻的临床研究.新医学,2012,43(3):155-158.B：其他排名论著13)ZhouH,WeiJ,DaiQ,WangL,LuoJ,CheangT,WangS.CaCO3/CaIP6compositenanoparticleseffectivelydeliverAKT1smallinterferingRNAtoinhibithumanbreastcancergrowth.IntJNanomedicine,2015Jul1;10:4255-66.(IF=4.383)14)QuMH,ZengRF,FangS,DaiQS,LiHP,LongJT.Liposome-basedco-deliveryofsiRNAanddocetaxelforthesynergistictreatmentoflungcancer.IntJPharm,2014Oct20;474(1-2):112-22.(IF=3.65)15)ChenC,SunP,RongJ,WengHW,DaiQS,YeS.ShortCourseRadiationintheTreatmentofLocalizedRectalCancer:ASystematicReviewandMeta-Analysis.SciRep.2015Jun9;5:10953.(IF=5.578)16)LongJ,ZhouB,LiH,DaiQ,ZhangB,XingS,ZengZ,ChenW,YangJ.ImprovementofHbsAgGene-ModifiedDendriticCell-BasedVaccineEfficacybyOptimizingImmunizationMethodortheApplicationofβ-glucosylceramide.ImmunolInvest.2013Jan16;42(2):137-55.(IF=1.991)17)LongJT,CheangTY,ZhuoSY,ZengRF,DaiQS,LiHP,FangS.Anticancerdrug-loadedmultifunctionalnanoparticlestoenhancethechemotherapeuticefficacyinlungcancermetastasis.JNanobiotechnology.2014Sep30;12(1):37.(IF=4.115)18)王天宝,戴强生,尉秀清,林维浩,石汉平,董文广.CXCR4RNA干扰序列筛选及对结肠癌细胞SW480生长的影响[J/CD].中华普通外科学文献:电子版,2012,6(5):394-399.专著：广东科学技术出版社《实用胃肠恶性肿瘤诊疗学》副主编其他主要工作成绩（比如情况）：
